NINR Funding Opportunities and Updates - 

Extramural Program Newsletter

This monthly newsletter for NINR applicants and awardees provides information about funding initiatives and other opportunities. View all recent Notices of Funding Opportunities (NOFOs) via the NIH Guide.

NINR-led Funding Opportunities

• NOT-NR-23-012: Notice of Special Interest (NOSI): Addressing Organizational Factors to Prevent or Mitigate Nurse Burnout seeks research studies to develop and evaluate novel organizational interventions to prevent and mitigate nurse burnout which will build new knowledge and the evidence base for implementation in places where nurses practice: in hospitals and clinics, in schools and workplaces, in homes and long-term care facilities, in justice settings, and throughout communities.
  • R01 Application Due Date: February 5, 2025
  • R21 Application Due Date: February 16, 2025
• RFA-NR-24-006: Understanding the Intersection of Social Inequities to Optimize Health and Reduce Health Disparities: The Axes Initiative (R01 Clinical Trial Optional). NINR has published a funding opportunity as part of the Axes Initiative inviting applications that address how social determinants of health (SDOH) influence health at the intersection of social statuses. Next Application Due Date: February 14, 2025
  • NINR held a Pre-Application Webinar for prospective applicants providing an overview of the funding opportunity and answering questions from potential applicants. Watch recording.

NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity 

• PAR-22-230: (R01 Clinical Trial Optional) solicits R01 grant applications that propose independent research projects that are consistent with the scientific framework detailed in the NINR Strategic Plan. Next Application Due Date: February 5, 2025
  • Please see Notice of Clarification NOT-NR-23-006 regarding Non-Responsive Applications. Updates shown in bold italics.
• PAR-22-231: (R21 Clinical Trial Optional) solicits R21 grant applications that propose exploratory/developmental research projects that are consistent with the research framework detailed in the NINR Strategic Plan. Next Application Due Date: February 16, 2025
  • Please see Notice of Clarification NOT-NR-23-007 regarding Non-Responsive Applications. Updates shown in bold italics.

This research will be rooted in nursing's holistic, contextualized approach to understanding people and their health, address the nation's most pressing and persistent health challenges with a solutions orientation, and employ innovative and rigorous study designs to inform practice and policy.

Participating Funding Opportunities

• PA-25-080: NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) will support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers. Next Application Due Date: December 12, 2024

• PA-24-255: Administrative Supplements to Promote Diversity in Research and Development Small Businesses – SBIR/STTR (Admin Supp Clinical Trial Not Allowed) notifies Small Business Concerns (SBCs) whose research is supported by Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants that funds are available for administrative supplements to enhance the diversity of the research and entrepreneurial workforce by recruiting, mentoring, and supporting students, postdoctoral scholars, and eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research or in the SBIR and STTR programs.

  • NINR accepts applications on a rolling basis. However, the parent grant should have a minimum of 6 months remaining at the time of award to support an optimal career development experience for the candidate. NINR will not award a diversity supplement to a grant in a no-cost extension.

• PAR-24-273: Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional) seeks to advance the science and implementation of innovative multi-level health care research for older adults from populations that experience health disparities. First Application Due Date: February 5, 2025

• NOT-DK-24-029: Notice of Special Interest (NOSI): Analysis of Existing Linked Datasets to Understand the Relationship between Housing Program Participation and Risk for Chronic Diseases and Other Conditions (R01-Clinical Trial Not Allowed) supports the evaluation of the effects of housing program participation on risk for chronic diseases and conditions within the missions of the participating Institutes and Offices. This NOSI applies to due dates on or after October 7, 2024

• Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00) seeks to facilitate a timely transition of promising postdoctoral researchers from diverse backgrounds from their mentored postdoctoral research positions to independent, tenure-track or equivalent research-intensive faculty positions. First AIDS Application Due Date: January 7, 2025; First Non-AIDS Application Due Date: February 12, 2025

  • PAR-24-225: Independent Clinical Trial Not Allowed

  • PAR-24-226: Independent Clinical Trial Required

• NOT-AI-24-059: Notice of Special Interest (NOSI): Ending the HIV Epidemic (EHE) solicits applications proposing research that is grounded in implementation science and can address the goals of the EHE initiative. This NOSI applies to due dates on or after September 7, 2024

• RFA-AT-24-010: Whole Person Research and Coordination Center (Whole Person RCC) U24 (Clinical Trial Not Allowed) solicits applications for the establishment of the Whole Person Research and Coordination Center under the NIH Whole Person Initiative. This center will be integral in coordinating the initial and future research programs in whole person health research. Application Due Date: November 1, 2024

• PAR-24-110: Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) will support non-pharmacological interventions to promote sleep health, reduce sleep health disparities, and examine sleep as a modifiable factor to reduce disparities for other health outcomes among populations that experience health disparities. First Application Due Date: February 5, 2025

• Mentored Research Scientist Development Award (Parent K01) provides support and “protected time” (three to five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. Next Application Due Date: February 12, 2025

  • PA-24-175: Independent Clinical Trial Required

  • PA-24-176: Independent Clinical Trial Not Allowed

  • PA-24-177: Independent Basic Experimental Studies with Humans Required

• NIH Pathway to Independence Award (Parent K99/R00) facilitates a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. Next Application Due Date: February 12, 2025

  • PA-24-193: Independent Clinical Trial Required

  • PA-24-194: Independent Clinical Trial Not Allowed

  • PA-24-195: Independent Basic Experimental Studies with Humans Required

• Midcareer Investigator Award in Patient-Oriented Research (Parent K24) provides support to mid-career health-professional doctorates for protected time to devote to patient-oriented research (POR) and to act as research mentors for junior clinical investigators pursuing POR research, such as clinical residents. Next Application Due Date: February 12, 2025

  • PA-24-187: Independent Clinical Trial Required

  • PA-24-188: Independent Clinical Trial Not Allowed

  • PA-24-189: Independent Basic Experimental Studies with Humans Required

• Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15) supports small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at applicant institutions. Next Application Due Date: October 25, 2024

  • PAR-24-152: Clinical Trial Not Allowed

  • PAR-24-214: Clinical Trial Required

• NOT-OD-24-079: Notice of Special Interest: Women’s Health Research, in alignment with the White House Initiative on Women’s Health Research, highlights interest in receiving research applications focused on diseases and health conditions that predominantly affect women (e.g., autoimmune diseases; depressive disorders, Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD), gender-based-violence), present and progress differently in women (e.g., cardiovascular disease; HIV; reproductive aging and its implications), or are female-specific (e.g., uterine fibroids; endometriosis; menopause). Applications accepted on a rolling basis.

• PAR-23-309: Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional) will support novel and innovative research that examines and/or intervenes on the underlying and multilevel causes, pathways, and factors adversely impacting the health and well-being of persons with disabilities at the intersections of race and ethnicity, and socioeconomic status. Next Application Due Date: February 5, 2025
• NOT-OD-24-058: Notice of Special Interest (NOSI): Developing and Testing Multi-level Physical Activity Interventions to Improve Health and Well-Being supports highly innovative multi-level interventions to increase and maintain health-enhancing physical activity in a wide range of population groups, including populations that experience health disparities, children, older adults, and persons at risk for mental/behavioral health conditions, and any subpopulations that can be characterized by the intersection of two or more of these descriptors. 
  • Next R01 Application Due Date: February 5, 2025
  • Next R21 Application Due Date: February 16, 2025
• PAR-23-303: Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01 - Clinical Trials Not Allowed) will support innovative, collaborative, and interdisciplinary research focused on clinical epidemiology, evaluation of public and/or health care policies, and validation of measurements that address health and healthcare disparities related to non-communicable and chronic diseases with the highest disease burden and mortality in Latin America and among U.S. Hispanics/Latinos. Next Application Due Date: February 5, 2025

• PAR-23-304: Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required) will support innovative and interdisciplinary team research focused on clinical, health services, and/or community-based interventions that address health and healthcare disparities related to non-communicable and chronic diseases with the highest disease burden and mortality in Latin America and among U.S. Hispanics/Latinos. Next Application Due Date: February 5, 2025

• PAR-24-059: Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional) will support multidisciplinary and innovative intervention research to understand and address maternal morbidity and mortality in the U.S., particularly but not exclusively among racial and ethnic minority, socioeconomically disadvantaged, and underserved rural populations, with a focus on understudied healthcare factors. Next Application Due Date: February 5, 2025

• NOT-OD-24-038: Notice of Special Interest: Health Influences of Gender as a Social and Structural Variable highlights interest in receiving research and training grant applications focused on health impacts of gender-related social and structural variables. 
  • Next F30, F31, and F32 Application Due Date: December 8, 2024
  • Next K01 and K23 Application Due Date: February 12, 2025
  • Next R01 Application Due Date: February 5, 2025
  • Next R21 Application Due Date: February 16, 2025
• RFA-MD-24-006: Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more populations that experience health disparities. Next Application Due Date: December 10, 2024
• RFA-MD-24-007: Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more NIH-defined populations that experience health disparities. Next Application Due Date: December 10, 2024

• PA-24-184: Mentored Patient-Oriented Research Career Development Award (Parent K23 - Independent Clinical Trial Required) specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary study to an existing trial. Next Application Due Date: February 12, 2025

• PA-24-185: Mentored Patient-Oriented Research Career Development Award (Parent K23 - Independent Clinical Trial Not Allowed) to support the career development of individuals with a clinical doctoral degree who have made a commitment to focus their research endeavors on patient-oriented research. Next Application Due Date: February 12, 2025
• PA-24-186: Mentored Patient-Oriented Research Career Development Award (Parent K23 - Independent Basic Experimental Studies with Humans Required) for basic science experimental studies involving humans. Next Application Due Date: February 12, 2025
• RFA-AA-24-006: Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required) supports the planning phase of the Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority Communities. MCCI is a multi-ICO dissemination and implementation science initiative to advance racial equity and end health disparities in racial/ethnic minority women and girls of reproductive age. Next Application Due Date: October 18, 2024

• PAR-23-285: Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) will support planning and development, including pilot or feasibility research, to improve health in Native American populations. Proposed research may address health promotion, disease prevention, treatment, recovery, or services research to inform intervention implementation and dissemination. First Application Due Date: October 21, 2024

• PAR-23-298: Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) will support research on interventions to improve health in Native American populations. This includes 1) etiologic research that will directly inform intervention development or adaptations, 2) research that develops, adapts, or tests interventions for health promotion, prevention, treatment, or recovery, and 3) where a sufficient body of knowledge on intervention efficacy exists, research on dissemination and implementation that develops and tests strategies to overcome barriers to the adoption, integration, scale-up, and sustainability of effective interventions. First Application Due Date: October 21, 2024

• PAR-23-299: Intervention Research to Improve Native American Health (R21 Clinical Trials Optional) will support developmental/exploratory research to improve health in Native American populations. This includes 1) etiologic research that will directly inform intervention development or adaptations, 2) research that develops, adapts, or tests interventions for health promotion, prevention, treatment, or recovery, and 3) where a sufficient body of knowledge on intervention efficacy exists, research on strategies to overcome barriers to the adoption, integration, scale-up, and sustainability of effective interventions. First Application Due Date: October 21, 2024

• NOT-OD-23-170: NOSI: Research Supplements to Promote Re-Entry, Re-integration into, and Re-training in Health-Related Research Careers (Admin Supp - Clinical Trial Not Allowed) will fund administrative supplements to provide full or part-time mentored research training experiences for individuals with high potential to re-enter, re-integrate into, or re-train in an active research career after an interruption for family responsibilities or other qualifying circumstances as described in the NOSI. NINR accepts administrative supplements on a rolling basis.

Presentations

Assessing the Impact of Pandemic Era Policies and Programs to Promote Food and Housing Security NINR is excited to present at APHA 2024 on nursing research assessing housing and food security policies and programs during the pandemic and their impact on health equity. Learn More.

The National Institute of Nursing Research Strategy for Promoting Health Equity Through Health and Housing Research NINR looks forward to presenting at APHA 2024 about promoting health equity through several research initiatives examining housing as a key social determinant of health. Learn More.